The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Sufentanil (API) Market Research Report 2025
Synopsis
Sufentanil, sold under the brand names Dsuvia and Sufenta, is a synthetic opioid analgesic drug approximately 5 to 10 times as potent as its parent drug, fentanyl, and 500 times as potent as morphine.
The global Sufentanil (API) market was valued at US$ 302 million in 2023 and is anticipated to reach US$ 523.9 million by 2030, witnessing a CAGR of 6.7% during the forecast period 2024-2030.
Sufentanil is a powerful analgesic drug with broad application prospects in the fields of medical services and drug therapy. In the next few years, the market size of sufentanil injection is expected to continue to expand and become an important pillar in the field of medical services and drug treatment.
This report aims to provide a comprehensive presentation of the global market for Sufentanil (API), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sufentanil (API).
Report Scope
The Sufentanil (API) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Sufentanil (API) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Sufentanil (API) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Kern Pharma
Cambrex
Hameln Rds
Cristalia
Janssen Pharmaceuticals
Segment by Type
Purity 98%
Purity 99%
Segment by Application
Injection
Capsule
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Sufentanil (API) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Sufentanil (API) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Sufentanil, sold under the brand names Dsuvia and Sufenta, is a synthetic opioid analgesic drug approximately 5 to 10 times as potent as its parent drug, fentanyl, and 500 times as potent as morphine.
The global Sufentanil (API) market was valued at US$ 302 million in 2023 and is anticipated to reach US$ 523.9 million by 2030, witnessing a CAGR of 6.7% during the forecast period 2024-2030.
Sufentanil is a powerful analgesic drug with broad application prospects in the fields of medical services and drug therapy. In the next few years, the market size of sufentanil injection is expected to continue to expand and become an important pillar in the field of medical services and drug treatment.
This report aims to provide a comprehensive presentation of the global market for Sufentanil (API), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sufentanil (API).
Report Scope
The Sufentanil (API) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Sufentanil (API) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Sufentanil (API) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Kern Pharma
Cambrex
Hameln Rds
Cristalia
Janssen Pharmaceuticals
Segment by Type
Purity 98%
Purity 99%
Segment by Application
Injection
Capsule
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Sufentanil (API) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Sufentanil (API) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Sufentanil (API) Market Overview
1.1 Product Overview and Scope of Sufentanil (API)
1.2 Sufentanil (API) Segment by Type
1.2.1 Global Sufentanil (API) Market Value Comparison by Type (2024-2030)
1.2.2 Purity 98%
1.2.3 Purity 99%
1.3 Sufentanil (API) Segment by Application
1.3.1 Global Sufentanil (API) Market Value by Application: (2024-2030)
1.3.2 Injection
1.3.3 Capsule
1.4 Global Sufentanil (API) Market Size Estimates and Forecasts
1.4.1 Global Sufentanil (API) Revenue 2019-2030
1.4.2 Global Sufentanil (API) Sales 2019-2030
1.4.3 Global Sufentanil (API) Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Sufentanil (API) Market Competition by Manufacturers
2.1 Global Sufentanil (API) Sales Market Share by Manufacturers (2019-2024)
2.2 Global Sufentanil (API) Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Sufentanil (API) Average Price by Manufacturers (2019-2024)
2.4 Global Sufentanil (API) Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Sufentanil (API), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Sufentanil (API), Product Type & Application
2.7 Sufentanil (API) Market Competitive Situation and Trends
2.7.1 Sufentanil (API) Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Sufentanil (API) Players Market Share by Revenue
2.7.3 Global Sufentanil (API) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Sufentanil (API) Retrospective Market Scenario by Region
3.1 Global Sufentanil (API) Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Sufentanil (API) Global Sufentanil (API) Sales by Region: 2019-2030
3.2.1 Global Sufentanil (API) Sales by Region: 2019-2024
3.2.2 Global Sufentanil (API) Sales by Region: 2025-2030
3.3 Global Sufentanil (API) Global Sufentanil (API) Revenue by Region: 2019-2030
3.3.1 Global Sufentanil (API) Revenue by Region: 2019-2024
3.3.2 Global Sufentanil (API) Revenue by Region: 2025-2030
3.4 North America Sufentanil (API) Market Facts & Figures by Country
3.4.1 North America Sufentanil (API) Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Sufentanil (API) Sales by Country (2019-2030)
3.4.3 North America Sufentanil (API) Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Sufentanil (API) Market Facts & Figures by Country
3.5.1 Europe Sufentanil (API) Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Sufentanil (API) Sales by Country (2019-2030)
3.5.3 Europe Sufentanil (API) Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Sufentanil (API) Market Facts & Figures by Country
3.6.1 Asia Pacific Sufentanil (API) Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Sufentanil (API) Sales by Country (2019-2030)
3.6.3 Asia Pacific Sufentanil (API) Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Sufentanil (API) Market Facts & Figures by Country
3.7.1 Latin America Sufentanil (API) Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Sufentanil (API) Sales by Country (2019-2030)
3.7.3 Latin America Sufentanil (API) Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Sufentanil (API) Market Facts & Figures by Country
3.8.1 Middle East and Africa Sufentanil (API) Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Sufentanil (API) Sales by Country (2019-2030)
3.8.3 Middle East and Africa Sufentanil (API) Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Sufentanil (API) Sales by Type (2019-2030)
4.1.1 Global Sufentanil (API) Sales by Type (2019-2024)
4.1.2 Global Sufentanil (API) Sales by Type (2025-2030)
4.1.3 Global Sufentanil (API) Sales Market Share by Type (2019-2030)
4.2 Global Sufentanil (API) Revenue by Type (2019-2030)
4.2.1 Global Sufentanil (API) Revenue by Type (2019-2024)
4.2.2 Global Sufentanil (API) Revenue by Type (2025-2030)
4.2.3 Global Sufentanil (API) Revenue Market Share by Type (2019-2030)
4.3 Global Sufentanil (API) Price by Type (2019-2030)
5 Segment by Application
5.1 Global Sufentanil (API) Sales by Application (2019-2030)
5.1.1 Global Sufentanil (API) Sales by Application (2019-2024)
5.1.2 Global Sufentanil (API) Sales by Application (2025-2030)
5.1.3 Global Sufentanil (API) Sales Market Share by Application (2019-2030)
5.2 Global Sufentanil (API) Revenue by Application (2019-2030)
5.2.1 Global Sufentanil (API) Revenue by Application (2019-2024)
5.2.2 Global Sufentanil (API) Revenue by Application (2025-2030)
5.2.3 Global Sufentanil (API) Revenue Market Share by Application (2019-2030)
5.3 Global Sufentanil (API) Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Kern Pharma
6.1.1 Kern Pharma Corporation Information
6.1.2 Kern Pharma Description and Business Overview
6.1.3 Kern Pharma Sufentanil (API) Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Kern Pharma Sufentanil (API) Product Portfolio
6.1.5 Kern Pharma Recent Developments/Updates
6.2 Cambrex
6.2.1 Cambrex Corporation Information
6.2.2 Cambrex Description and Business Overview
6.2.3 Cambrex Sufentanil (API) Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Cambrex Sufentanil (API) Product Portfolio
6.2.5 Cambrex Recent Developments/Updates
6.3 Hameln Rds
6.3.1 Hameln Rds Corporation Information
6.3.2 Hameln Rds Description and Business Overview
6.3.3 Hameln Rds Sufentanil (API) Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Hameln Rds Sufentanil (API) Product Portfolio
6.3.5 Hameln Rds Recent Developments/Updates
6.4 Cristalia
6.4.1 Cristalia Corporation Information
6.4.2 Cristalia Description and Business Overview
6.4.3 Cristalia Sufentanil (API) Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Cristalia Sufentanil (API) Product Portfolio
6.4.5 Cristalia Recent Developments/Updates
6.5 Janssen Pharmaceuticals
6.5.1 Janssen Pharmaceuticals Corporation Information
6.5.2 Janssen Pharmaceuticals Description and Business Overview
6.5.3 Janssen Pharmaceuticals Sufentanil (API) Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Janssen Pharmaceuticals Sufentanil (API) Product Portfolio
6.5.5 Janssen Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Sufentanil (API) Industry Chain Analysis
7.2 Sufentanil (API) Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Sufentanil (API) Production Mode & Process
7.4 Sufentanil (API) Sales and Marketing
7.4.1 Sufentanil (API) Sales Channels
7.4.2 Sufentanil (API) Distributors
7.5 Sufentanil (API) Customers
8 Sufentanil (API) Market Dynamics
8.1 Sufentanil (API) Industry Trends
8.2 Sufentanil (API) Market Drivers
8.3 Sufentanil (API) Market Challenges
8.4 Sufentanil (API) Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Sufentanil (API) Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Sufentanil (API) Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Sufentanil (API) Market Competitive Situation by Manufacturers in 2023
Table 4. Global Sufentanil (API) Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Sufentanil (API) Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Sufentanil (API) Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Sufentanil (API) Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Sufentanil (API) Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Sufentanil (API), Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Sufentanil (API), Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Sufentanil (API), Product Type & Application
Table 12. Global Key Manufacturers of Sufentanil (API), Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Sufentanil (API) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sufentanil (API) as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Sufentanil (API) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Sufentanil (API) Sales by Region (2019-2024) & (K Units)
Table 18. Global Sufentanil (API) Sales Market Share by Region (2019-2024)
Table 19. Global Sufentanil (API) Sales by Region (2025-2030) & (K Units)
Table 20. Global Sufentanil (API) Sales Market Share by Region (2025-2030)
Table 21. Global Sufentanil (API) Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Sufentanil (API) Revenue Market Share by Region (2019-2024)
Table 23. Global Sufentanil (API) Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Sufentanil (API) Revenue Market Share by Region (2025-2030)
Table 25. North America Sufentanil (API) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Sufentanil (API) Sales by Country (2019-2024) & (K Units)
Table 27. North America Sufentanil (API) Sales by Country (2025-2030) & (K Units)
Table 28. North America Sufentanil (API) Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Sufentanil (API) Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Sufentanil (API) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Sufentanil (API) Sales by Country (2019-2024) & (K Units)
Table 32. Europe Sufentanil (API) Sales by Country (2025-2030) & (K Units)
Table 33. Europe Sufentanil (API) Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Sufentanil (API) Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Sufentanil (API) Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Sufentanil (API) Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Sufentanil (API) Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Sufentanil (API) Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Sufentanil (API) Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Sufentanil (API) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Sufentanil (API) Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Sufentanil (API) Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Sufentanil (API) Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Sufentanil (API) Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Sufentanil (API) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Sufentanil (API) Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Sufentanil (API) Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Sufentanil (API) Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Sufentanil (API) Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Sufentanil (API) Sales (K Units) by Type (2019-2024)
Table 51. Global Sufentanil (API) Sales (K Units) by Type (2025-2030)
Table 52. Global Sufentanil (API) Sales Market Share by Type (2019-2024)
Table 53. Global Sufentanil (API) Sales Market Share by Type (2025-2030)
Table 54. Global Sufentanil (API) Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Sufentanil (API) Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Sufentanil (API) Revenue Market Share by Type (2019-2024)
Table 57. Global Sufentanil (API) Revenue Market Share by Type (2025-2030)
Table 58. Global Sufentanil (API) Price (US$/Unit) by Type (2019-2024)
Table 59. Global Sufentanil (API) Price (US$/Unit) by Type (2025-2030)
Table 60. Global Sufentanil (API) Sales (K Units) by Application (2019-2024)
Table 61. Global Sufentanil (API) Sales (K Units) by Application (2025-2030)
Table 62. Global Sufentanil (API) Sales Market Share by Application (2019-2024)
Table 63. Global Sufentanil (API) Sales Market Share by Application (2025-2030)
Table 64. Global Sufentanil (API) Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Sufentanil (API) Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Sufentanil (API) Revenue Market Share by Application (2019-2024)
Table 67. Global Sufentanil (API) Revenue Market Share by Application (2025-2030)
Table 68. Global Sufentanil (API) Price (US$/Unit) by Application (2019-2024)
Table 69. Global Sufentanil (API) Price (US$/Unit) by Application (2025-2030)
Table 70. Kern Pharma Corporation Information
Table 71. Kern Pharma Description and Business Overview
Table 72. Kern Pharma Sufentanil (API) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Kern Pharma Sufentanil (API) Product
Table 74. Kern Pharma Recent Developments/Updates
Table 75. Cambrex Corporation Information
Table 76. Cambrex Description and Business Overview
Table 77. Cambrex Sufentanil (API) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Cambrex Sufentanil (API) Product
Table 79. Cambrex Recent Developments/Updates
Table 80. Hameln Rds Corporation Information
Table 81. Hameln Rds Description and Business Overview
Table 82. Hameln Rds Sufentanil (API) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Hameln Rds Sufentanil (API) Product
Table 84. Hameln Rds Recent Developments/Updates
Table 85. Cristalia Corporation Information
Table 86. Cristalia Description and Business Overview
Table 87. Cristalia Sufentanil (API) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Cristalia Sufentanil (API) Product
Table 89. Cristalia Recent Developments/Updates
Table 90. Janssen Pharmaceuticals Corporation Information
Table 91. Janssen Pharmaceuticals Description and Business Overview
Table 92. Janssen Pharmaceuticals Sufentanil (API) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Janssen Pharmaceuticals Sufentanil (API) Product
Table 94. Janssen Pharmaceuticals Recent Developments/Updates
Table 95. Key Raw Materials Lists
Table 96. Raw Materials Key Suppliers Lists
Table 97. Sufentanil (API) Distributors List
Table 98. Sufentanil (API) Customers List
Table 99. Sufentanil (API) Market Trends
Table 100. Sufentanil (API) Market Drivers
Table 101. Sufentanil (API) Market Challenges
Table 102. Sufentanil (API) Market Restraints
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Sufentanil (API)
Figure 2. Global Sufentanil (API) Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Sufentanil (API) Market Share by Type in 2023 & 2030
Figure 4. Purity 98% Product Picture
Figure 5. Purity 99% Product Picture
Figure 6. Global Sufentanil (API) Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Sufentanil (API) Market Share by Application in 2023 & 2030
Figure 8. Injection
Figure 9. Capsule
Figure 10. Global Sufentanil (API) Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 11. Global Sufentanil (API) Market Size (2019-2030) & (US$ Million)
Figure 12. Global Sufentanil (API) Sales (2019-2030) & (K Units)
Figure 13. Global Sufentanil (API) Average Price (US$/Unit) & (2019-2030)
Figure 14. Sufentanil (API) Report Years Considered
Figure 15. Sufentanil (API) Sales Share by Manufacturers in 2023
Figure 16. Global Sufentanil (API) Revenue Share by Manufacturers in 2023
Figure 17. The Global 5 and 10 Largest Sufentanil (API) Players: Market Share by Revenue in 2023
Figure 18. Sufentanil (API) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 19. Global Sufentanil (API) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 20. North America Sufentanil (API) Sales Market Share by Country (2019-2030)
Figure 21. North America Sufentanil (API) Revenue Market Share by Country (2019-2030)
Figure 22. U.S. Sufentanil (API) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 23. Canada Sufentanil (API) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Europe Sufentanil (API) Sales Market Share by Country (2019-2030)
Figure 25. Europe Sufentanil (API) Revenue Market Share by Country (2019-2030)
Figure 26. Germany Sufentanil (API) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. France Sufentanil (API) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. U.K. Sufentanil (API) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Italy Sufentanil (API) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Russia Sufentanil (API) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Asia Pacific Sufentanil (API) Sales Market Share by Region (2019-2030)
Figure 32. Asia Pacific Sufentanil (API) Revenue Market Share by Region (2019-2030)
Figure 33. China Sufentanil (API) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Japan Sufentanil (API) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. South Korea Sufentanil (API) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. India Sufentanil (API) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Australia Sufentanil (API) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Taiwan Sufentanil (API) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Indonesia Sufentanil (API) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Thailand Sufentanil (API) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Malaysia Sufentanil (API) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Philippines Sufentanil (API) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Latin America Sufentanil (API) Sales Market Share by Country (2019-2030)
Figure 44. Latin America Sufentanil (API) Revenue Market Share by Country (2019-2030)
Figure 45. Mexico Sufentanil (API) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Brazil Sufentanil (API) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Argentina Sufentanil (API) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Sufentanil (API) Sales Market Share by Country (2019-2030)
Figure 49. Middle East & Africa Sufentanil (API) Revenue Market Share by Country (2019-2030)
Figure 50. Turkey Sufentanil (API) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Saudi Arabia Sufentanil (API) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. UAE Sufentanil (API) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Global Sales Market Share of Sufentanil (API) by Type (2019-2030)
Figure 54. Global Revenue Market Share of Sufentanil (API) by Type (2019-2030)
Figure 55. Global Sufentanil (API) Price (US$/Unit) by Type (2019-2030)
Figure 56. Global Sales Market Share of Sufentanil (API) by Application (2019-2030)
Figure 57. Global Revenue Market Share of Sufentanil (API) by Application (2019-2030)
Figure 58. Global Sufentanil (API) Price (US$/Unit) by Application (2019-2030)
Figure 59. Sufentanil (API) Value Chain
Figure 60. Sufentanil (API) Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
